My Alerts: Columnists

Medscape's Editor-in-Chief, Eric Topol, MD, is a practicing cardiologist and a recognized leader in the fields of genomic and digital medicine. He is a professor of genomics at the Scripps Research Institute and chief academic officer of Scripps Health. His frequent contributions to Medscape include interviews with key thought leaders in medicine.

Arthur L. Caplan, PhD, is director of the Division of Medical Ethics at New York University Langone Medical Center and School of Medicine, New York, New York.

George Lundberg, MD, is an internationally recognized pathologist and former editor-in-chief of Medscape and JAMA. He presents commentary on a range of topics, including medical ethics, social determinants of health, the business of healthcare, and trends in research.

In our Morning Report, Drs. Arefa Cassoobhoy and Chuck Vega provide 1-minute updates and key actionable takeaways on studies and guidelines across the range of conditions seen in primary care.

Gary Stadtmauer, MD, is an assistant clinical professor and staff physician at Mount Sinai School of Medicine in New York, NY. He presents commentary and practical pointers on treating allergic diseases and asthma.

The Bob Harrington Show is a podcast series of thoughtful interviews and discussions on topics at the core of cardiology and the practice of medicine.

Interventional cardiologist Jaya Mallidi, MD writes about the challenges of contemporary practice.

Electrophysiologist, competitive biker, blogger, and teacher John Mandrola, MD, shares his thoughts on the world of electrophysiology and medicine.

Heart-failure (HF) specialist Ileana Piña, MD, MPH shares her views and interviews colleagues about HF and cardiology.

Melissa Walton-Shirley, MD, brings a personal and practice-focused perspective to headlines, research, and overlooked cardiology gems.

Dr. Michelle O'Donoghue discusses the latest research and challenges facing the cardiology practitioner.

Dr Aaron Holley is an associate professor of medicine at Uniformed Services University and program director of pulmonary and critical care medicine at Walter Reed National Military Medical Center. He covers a wide range of topics in pulmonary, critical care, and sleep medicine.

Graeme Lipper, MD, uses his long and varied experience in dermatology to analyze and discuss the latest news and innovations in the field.

Harpreet S. Bajaj, MD, MPH, is an endocrinologist and a Research Associate at Mount Sinai Hospital in Toronto, Canada. He is the founder of the STOP Diabetes Foundation in Toronto.

Yoni Freedhoff, MD, Associate Professor, Department of Family Medicine, University of Ottawa; Medical Director, Bariatric Medical Institute, Ottawa, Ontario, Canada, discusses obesity and health.

Jessica Sparks Lilley, MD, Director of Pediatric Diabetes and Lipid Program, Mississippi Center for Advanced Medicine, Madison, Mississippi, covers the latest pediatric endocrinology issues.

Gregory A. Nichols, PhD, is a Senior Investigator at the Kaiser Permanente Center for Health Research in Portland, Oregon. He writes about research in diabetes care, including his own studies and publications.

Anne Peters, MD, helps clinicians keep up with the latest news in diabetes care. Her commentaries cover new practice guidelines, emerging research, treatment controversies, and more.

Richard M. Plotzker, MD, is a staff physician at Mercy Philadelphia Hospital in Philadelphia, Pennsylvania. His regular columns describe the issues faced by practicing endocrinologists, often with a touch of humor.

In this series, Jay Shubrook, DO, a primary care diabetologist and professor of medicine at Touro University, interviews other leading experts about best strategies to manage patients with type 2 diabetes in the primary care setting.

Robert Glatter, MD, is a practicing emergency physician, and assistant professor of emergency medicine at Northwell Health, Lenox Hill Hospital, providing unique viewpoints and commentary on breaking medical stories, key medical studies, and new and emerging trends in healthcare.

David A. Johnson, MD, is professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia. He regularly offers his perspective on current topics in gastroenterology.

Paul Sax, MD, clinical director of the HIV Program and Division of Infectious Diseases at Brigham and Women's Hospital, provides his perspective on the most important HIV studies presented at research meetings, as well as other advances in HIV care.

Paul G. Auwaerter, MD, is Clinical Director of the Division of Infectious Diseases at Johns Hopkins University School of Medicine, in Baltimore, MD. He offers commentary on a variety of trending topics in infectious diseases.

Paul A. Offit, MD, is director of the Vaccine Education Center at the Children's Hospital of Philadelphia (CHOP) in Pennsylvania. He contributes regular commentaries on vaccine-related topics in infectious disease.

Expert commentary on the latest Nephrology studies from Tejas P. Desai, MD and Nisha Bansal, MD, MAS.

Lynda Szczech, MD, MSE, is a practicing nephrologist in Durham, North Carolina. She raises awareness on emotional issues surrounding patient care, and discusses a wide range of topics in nephrology, including dialysis, chronic kidney and end-stage renal disease management.

Mark J. Alberts, MD, is vice-chair of the Department of Neurology and Neurotherapeutics at UT Southwestern Medical Center in Dallas, Texas. He comments on issues and advances in stroke management.

Dr. Isaacson is an associate professor in the Department of Neurology at Weill Cornell Medicine in New York City. Here he covers the latest advances in the prevention and management of Alzheimer’s disease.

Andrew N. Wilner, MD, is a neurohospitalist in the Department of Neurology at Lawrence + Memorial Hospital in New London, Connecticut. His column covers issues in pathophysiology, diagnosis, and management of seizures.

Bishal Gyawali, MD, PhD, is an assistant professor in the Department of Public Health Sciences, a scientist in the Division of Cancer Care and Epidemiology, and a clinical fellow in the Department of Medical Oncology at Queen's University in Kingston, Ontario, Canada, and is also affiliated faculty at the Program on Regulation, Therapeutics, and Law in the Department of Medicine at Brigham and Women's Hospital in Boston. His clinical and research interests revolve around cancer policy, global oncology, evidence-based oncology, financial toxicities of cancer treatment, clinical trial methods, and supportive care.

David J. Kerr, CBE, MD, DSc, FRCP, FMedSci, is a professor in the Nuffield Department of Clinical Laboratory Science at the University of Oxford, and professor of cancer medicine at Oxford Cancer Centre in Oxford, United Kingdom. He presents commentary on gastrointestinal cancers, cancer prevention, and issues in global oncology.

Mark Kris, MD, of Memorial Sloan Kettering Cancer Center, discusses advances in lung cancer, including hard-to-treat clinical scenarios and major research trials.

Mark A. Lewis, MD, is director of gastrointestinal oncology at Intermountain Healthcare in Utah. Specializing in cancers of the gastrointestinal tract and accessory organs, his interests focus on hereditary cancer syndromes and young-onset cancers, shared decision-making, and patient-physician communication.

Maurie Markman, MD, of Cancer Treatment Centers of America, provides his perspective on developments in the gynecologic cancers, with a focus on published studies and their implications for patient management.

John L. Marshall, MD, is a professor in the Division of Hematology-Oncology at Georgetown University, and director of the Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center in Washington, DC. He offers commentary on gastrointestinal cancers, genomic medicine, and factors affecting cancer costs and practice.

Kathy D. Miller, MD, is a professor at Indiana University and co-director of the Indiana University Simon Cancer Center Breast Cancer Program, in Indianapolis, Indiana. She presents commentary on breast cancer, cancer prevention, and factors affecting the practice of oncology.

Ravi B. Parikh, MD, MPP, is a fellow in hematology/oncology at the University of Pennsylvania, an adjunct fellow at the Leonard Davis Institute of Health Economics, and senior clinical advisor at the Coalition to Transform Advanced Care (C-TAC). His research and writing focus on policy and innovation in cancer care, with specific interests in advanced illness and predictive analytics. He has published widely in popular and academic press. Dr Parikh is a graduate of Harvard Medical School, John F. Kennedy School of Government, and Harvard College.

Lidia Schapira, MD, associate professor of oncology at Stanford, provides viewpoints on breast cancer research and the special concerns of young cancer survivors, as well as the psychosocial support of cancer patients and improved patient-physician communication.

Jeffrey S. Weber, MD, PhD, is deputy director of the Perlmutter Cancer Center at New York University, where he works with a multidisciplinary team to treat patients with melanomas ranging from the most common to the most complex. He is also co-director of the Melanoma Research Program, overseeing work in experimental therapeutics with a focus on immunotherapy for cancer.

H. Jack West, MD, is an Associate Clinical Professor and the Executive Director of Employer Services at City of Hope Comprehensive Cancer Center in Duarte, CA. He is also the web editor of JAMA Oncology and the founder and president of the nonprofit organization Global Resource for Advancing Cancer Education (GRACE), which provides information for patients and caregivers dealing with cancer. Dr West leads a wide range of continuing medical education programs and other educational programs, including hosting the audio podcast, West Wind.

Douglas Paauw, MD, a primary care internist and professor of medicine at the University of Washington, challenges primary care clinicians with patient scenarios related to adverse events from a number of pharmacologic drugs commonly used in primary care.

In this series, Charles Vega, MD, a clinical professor in family medicine at the University of California, Irvine, interviews a range of experts about changing trends and information in the care of patients with the most common conditions seen in primary care.

Jeffrey A. Lieberman, MD, is professor and chair in the Department of Psychiatry at Columbia University College of Physicians and Surgeons in New York, New York. He discusses a wide range of psychiatry topics, including policy, scientific advancements, and treatments.

Jonathan Kay, MD, is professor of medicine at University of Massachusetts Medical School and director of clinical research in the Division of Rheumatology at UMass Memorial Medical Center in Worcester, Massachusetts. He covers a wide range of rheumatology topics, from RA, to gout, to the history of rheumatologic conditions.

JoAnn E. Manson, MD, DrPH, is the Michael and Lee Bell Professor of Women's Health at Harvard Medical School and chief of preventive medicine at Brigham and Women's Hospital in Boston.